The critically ill patient exhibits a well defined endocrine and metabolic
adaptive response to stressor agents, characterized by incremented resting
energy expenditure (hypermetabolism, which is believed to signify increased
energy requirements), accelerated whole-body proteolysis (hypercatabolism)
, and lipolysis. These phenomena occur in the acute stage, which is also ch
aracterized by hyperglycemia, typically accompanied by a hyperdynamic cardi
ovascular reaction manifested by high cardiac output, increased oxygen cons
umption, high body temperature, and decrease peripheral vascular resistance
. High provisions of glucose-derived calories tend to accentuate these reac
tions and increase the degree of hyperglycemia. We have adopted a hypocalor
ic-hyperproteic regimen which is provided only during the first days of the
flow phase of the adaptive response to injury, sepsis, or critical illness
. Our regimen includes a daily supply of 100 to 200 g of glucose and 1.5 to
2.0 g of protein (synthetic amino acids) per kilogram of ideal body weight
. We have analyzed the data on 107 critically ill patients, 70 men and 37 w
omen, who were admitted to the surgical intensive care unit and who receive
d nutritional support by the TPN hypocaloric modality for a minimum of 3 da
ys. We found that the high caloric loads contained in TPN regimens results
in additional metabolic stress, with consequent hyperdynamic cardiorespirat
ory repercussion, high CO2 production, and frequently hepatic steatosis. In
contrast, our hypocaloric-hyperproteic approach has resulted in a more phy
siologic clinical course and considerable reduction in cost. The infusion o
f high glucose loads, such as those used in hypercaloric TPN, does not seem
to suppress the excessive endogenous production of glucose but instead mar
kedly exacerbates the hyperglycemia of the postinjury and acute stress cond
ition. We believe that the hypocaloric-hyperproteic regimen we utilize duri
ng the first few days of the stress situation is more in accordance with th
e inflammatory and hormonal mediator climate of the initial stages of the f
low phase and thus appears to be beneficial vis-a-vis the hypercaloric load
s that many use as routine metabolic support in critically ill patients.